Advertisement

Topics

PhotoCure ASA Company Profile

23:39 EDT 23rd September 2018 | BioPortfolio

PhotoCure ASA is a Norwegian company that develops and sells pharmaceuticals and medical devices based on its proprietary photodynamic therapy (PDT) technologies, targeting key dermatology and oncology markets.

Location

Hoffsveien 48
Oslo
0377
Norway

Contact

Phone: 47 22 06 22 10
Fax: 47 22 06 22 18
Email: kjetil.hestdal@photocure.no


News Articles [20 Associated News Articles listed on BioPortfolio]

Photocure ASA: Mandatory notification of trade

Jan H. Egberts, Chairperson of the Board of Photocure ASA and primary insider in Photocure ASA, has on 7 June 2018 purchased 12,500 shares in Photocure ASA at a price of NOK 27.6687 per share...

Photocure ASA: Purchase own shares

Reference is made to the stock exchange release on 7 May 2018 announcing a repurchase of 13,000 own shares. Photocure ASA purchased today, 8 May 2018, 13,000 own shares. The shares were...

Photocure ASA: Annual accounts 2017

Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017. The annual accounts and annual report for the financial year 2017...

Photocure ASA: Notice of the annual general meeting 9 May 2018

Oslo, 16 April 2018: Photocure ASA (OSE: PHO), calls for the annual general meeting of PHO to be held at Hoffsveien 4, 1st floor, 0275 Oslo, Norway on 9 May 2018 at 17:00 hours (CET). The...

Photocure ASA: Presentation of the second quarter and first half year 2018 results

Photocure will present its second quarter and first half year report on Wednesday 8 August 2018 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and repres...

Photocure (PHO) - US growth accelerating

Edison Investment Research - Pharmaceutical & healthcare - Photocure: Photocure announced results for Q218 with 16% revenue growth compared to Q217. Revenue growth accelerated in the US, where Hexvix/...

Photocure ASA: Annual general meeting held

Oslo, Norway, 9 May 2018: Photocure ASA (OSE: PHO), held its annual general meeting on 9 May 2018 at 17:00 hours (CET). All proposals were resolved as presented in the notice convening t...

Photocure (PHO) - Q4 results and a new indication

Edison Investment Research - Pharmaceutical & healthcare - Photocure: Photocure announced results for Q417 with 25% growth for the Hexvix/Cysview franchise compared to Q416. For the year, Hexvix/Cysvi...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Cysview [Photocure Inc.]

These highlights do not include all the information needed to use Cysview safely and effectively. See full prescribing information for Cysview. Cysview (hexaminolevulinate hydrochloride), for Intraves...

Metvixia™ (methyl aminolevulinate) cream, 16.8%for topical use only. not for ophthalmic, oral, or intravaginal usemust be dispensed to and applied by a physician. [Penn Pharmaceutical Services Ltd.]

METVIXIA™ (methyl aminolevulinate) Cream, 16.8%For Topical Use Only. Not for Ophthalmic, Oral, or Intravaginal UseMust be dispensed to and applied by a physician.

Cysview [GE Healthcare Inc.]

These highlights do not include all the information needed to use Cysview safely and effectively. See full prescribing information for Cysview. Cysview (hexaminolevulinate hydrochloride), for Intraves...

Metvixia [Galderma Laboratories, L.P.]

These highlights do not include all the information needed to use METVIXIA safely and effectively.See full prescribing information for METVIXIA. METVIXIA™ (methyl aminolevulinate) Cream, 16.8%For To...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Companies [2 Associated Companies listed on BioPortfolio]

PhotoCure

PhotoCure is engaged in the research and development of novel therapeutics and diagnostics and related medical devices based on its proprietary photodynamic therapy (PDT) technologies. PDT is a two st...

PhotoCure ASA

PhotoCure ASA is a Norwegian company that develops and sells pharmaceuticals and medical devices based on its proprietary photodynamic therapy (PDT) technologies, targeting key dermatology and oncolog...

More Information about "PhotoCure ASA" on BioPortfolio

We have published hundreds of PhotoCure ASA news stories on BioPortfolio along with dozens of PhotoCure ASA Clinical Trials and PubMed Articles about PhotoCure ASA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PhotoCure ASA Companies in our database. You can also find out about relevant PhotoCure ASA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record